Top Stories
-
In this Q&A, Edmond Chan discusses his current work on synthetic lethality, including an ongoing clinical trial and major new basic research findings.
Topic
-
Explore pioneering work in AI, cell therapy and immunotherapy, and our approach to compassionate, community-informed care in the 2024 Pathways to a Cure annual report.
Topic
-
A Columbia clinical trial led by Hua-Jay Cherng, MD, will partner with Foresight Diagnostics to evaluate more personalized cancer treatments for patients with diffuse large B-cell lymphoma (DLBCL)..
Topic
-
Columbia physician-scientist Ryan Moy, MD, PhD, is pioneering research in gastric cancer, including a promising new clinical trial using pill-based therapies to treat diffuse gastric cancer.
Topic
Latest News
-
Source:
CUIMC NewsroomSeptember 23, 2022As part of the Biden Administration's Cancer Moonshot initiative, First Lady Jill Biden and Queen Letizia of Spain visited Columbia University's cancer center on Sept. 21.
Topic
- September 21, 2022
First Lady Jill Biden and Queen Letizia of Spain underscore Columbia Cancer's work in addressing health inequities, improving diversity in clinical trials and advancing critical cancer research.
- July 18, 2022
Under her directorship, Dr. Karen Antman led the expansion of the Cancer Center's clinical arm, infrastructure and multi-disciplinary care.
-
Source:
NRG OncologyJune 28, 2022Dr. Andrew Lassman: "These trials transformed our understanding of the clinical behavior of molecularly defined gliomas and contributed to the classification of gliomas used globally today."
Topic
-
Source:
SWOG Cancer Research NetworkMay 27, 2022A study, led by Dr. Dawn Hershman, tested whether standing orders embedded in electronic medical records systems could improve prescribing practice for CSFs and lower incidence of febrile neutropenia.
Topic
- March 28, 2022
A new study led by Dr. Andrew Lassman addresses safety and efficacy of infigratinib, a fibroblast growth factor receptor (FGFR)-tyrosine kinase inhibitor, for patients with recurrent glioblastomas.
Topic
- February 9, 2022
Carmela Brunelli has remained in remission after completing a trial that offers a promising, entirely new bladder-saving treatment option for patients.
Topic
- February 4, 2022
A clinical trial led by Columbia neuro-oncology team suggests that a new type of anti-cancer drug has promise for patients with glioblastoma.
- October 29, 2021
Sharon Howell had an encouraging response as a patient in the I-SPY clinical trials, and the outcome could also translate to a lower likelihood of her cancer coming back in the future.
Topic
- September 9, 2021
The new $10 million Columbia-Pfizer Clinical Trials Diversity Initiative will aim to reduce health disparities by increasing the participation of underrepresented minorities in clinical trials.
Topic
